Search

Takeda Pharmaceutical Co Ltd ADR

Ouvert

SecteurSoins de santé

18.48 0.65

Résumé

Variation du prix de l'action

24h

Actuel

Min

18.22

Max

18.45

Chiffres clés

By Trading Economics

Revenu

138B

113B

Ventes

105B

1.2T

P/E

Moyenne du Secteur

42.622

47.946

BPA

0.48

Rendement du dividende

3.45

Marge bénéficiaire

9.279

Employés

47,029

EBITDA

180B

337B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+136.38% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

3.45%

2.27%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.2B

57B

Ouverture précédente

17.83

Clôture précédente

18.48

Sentiment de l'Actualité

By Acuity

50%

50%

133 / 340 Classement par Healthcare

Takeda Pharmaceutical Co Ltd ADR Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 oct. 2026, 23:55 UTC

News

Aptiv PLC shares traded modestly lower in after-hours action following UBS's Buy rating and a lowered price target of $57.

7 oct. 2026, 23:51 UTC

News

Hilton Worldwide Holdings Inc is trading modestly lower in after-market hours, breaking a recent trend of higher daily closes amid broader market shifts.

7 oct. 2026, 23:45 UTC

News

Pinterest Inc launched Beauty Guides, an AI tool for style communication, as shares advanced modestly in after-market trading, reaching over half a percent above Wednesday's close.

7 oct. 2026, 23:45 UTC

News

Lattice Semiconductor Corp partners with Arm to enhance AI data center security, gaining slightly in after-market trading and showcasing at the OCP Global Summit 2026.

7 oct. 2026, 23:45 UTC

News

EMCOR Group Inc. is trading modestly higher in after-market hours, supported by strong earnings of $547.3 million amid increased interest in data-center construction.

7 oct. 2026, 23:45 UTC

News

Xpeng Inc's G9L model completed its first production trial in Austria, while shares are trading lower in after-market hours, below the 20-day moving average.

7 oct. 2026, 23:41 UTC

News

Hims & Hers Health appoints Jon Franklin as Chief Accounting Officer, effective immediately, as shares move higher in after-market trading.

7 oct. 2026, 23:40 UTC

News

Mid-America Apartment Communities Inc will release its Q3 2026 earnings on October 28, contributing to positive investor sentiment as shares rise in after-market trading.

7 oct. 2026, 23:35 UTC

Social Media
News

IBM has advanced to Stage C of the DARPA Quantum Benchmarking Initiative, aiming for a fault-tolerant quantum computer by 2029, with shares roughly flat in after-market trading.

7 oct. 2026, 23:35 UTC

Correlated Moves
News

Truist Financial shares are modestly lower in after-market trading following TD Cowen's Hold rating, reflecting broader declines in the Vanguard Morningstar Value ETF.

7 oct. 2026, 23:30 UTC

News

Invitation Homes Inc. announced its Q3 2026 earnings release date for October 28, 2026, with shares moving modestly higher in after-market trading.

7 oct. 2026, 23:20 UTC

News

U.S. Bancorp shares have moved higher in after-market trading following TD Cowen's resumption of coverage with a Buy rating.

7 oct. 2026, 23:20 UTC

News

Avery Dennison Corp's shares advanced modestly in after-market trading, recovering from earlier losses and remaining near the lower end of their one-month trading range.

7 oct. 2026, 23:20 UTC

News

UBS maintained its Buy rating on RPM International Inc, lowering its price target to $128, as shares gain slightly in after-market trading.

7 oct. 2026, 23:15 UTC

News

APA Corp reported preliminary Q3 2026 financial data, including average realized oil prices of $87.50 in the U.S., with shares trading higher in after-market hours.

7 oct. 2026, 23:11 UTC

News

The USD/DKK is trading modestly higher, supported by a weaker euro and concerns over European economic conditions amid rising oil prices and geopolitical tensions.

7 oct. 2026, 23:11 UTC

News

Bitcoin fell as it approached the $83k to $84k range, following a failure to break $87k resistance and amid rising oil prices and Fed rate hike signals.

7 oct. 2026, 23:11 UTC

News

Bitcoin is trading lower for a third consecutive session, nearing the $83k to $84k range amid $550 million in liquidations and rising oil prices.

7 oct. 2026, 23:11 UTC

News

Ethereum is declining for a third straight session amid geopolitical tensions and a broader cryptocurrency sell-off, with Bitcoin liquidations around $550 million.

7 oct. 2026, 23:11 UTC

News

Ethereum is trading lower amid geopolitical tensions and a broader cryptocurrency sell-off, with Bitcoin liquidations around $550 million contributing to market volatility.

7 oct. 2026, 23:06 UTC

News
Social Media

Rivian Automotive Inc secured a $1 billion loan facility from Volkswagen Group, with shares rising slightly in after-market trading following the announcement.

7 oct. 2026, 23:06 UTC

News

The USD/NOK is trading slightly higher as the Federal Reserve's September meeting minutes indicate strong support for another interest rate hike by year-end.

7 oct. 2026, 23:06 UTC

Correlated Moves
News

Shell PLC's shares rose in after-market hours, buoyed by EOG Resources' strong performance and the company's collaboration with Airsys on energy-efficient cooling solutions.

7 oct. 2026, 23:06 UTC

News

Liquidia Corporation's stock trades lower in after-market hours amid an investigation into potential securities law violations following a court ruling on United Therapeutics' patent.

7 oct. 2026, 23:06 UTC

News

EUR/GBP is trading slightly lower, remaining flat since Tuesday's close, and positioned below its 20-day moving average amid Germany's industrial production recovery.

7 oct. 2026, 23:06 UTC

News
Correlated Moves

The USD/PLN is trading modestly higher, influenced by retail commentary on the 101.80 level and the euro's decline against major currencies.

7 oct. 2026, 23:06 UTC

News
Correlated Moves

The USD/CZK is trading modestly higher as the euro weakens amid economic concerns in Europe and signals of a potential Fed interest rate hike.

7 oct. 2026, 23:05 UTC

News

Verizon Communications Inc is enhancing connectivity measures in response to Tropical Storm Isaias, contributing to a modest after-market hours gain in its shares.

7 oct. 2026, 23:05 UTC

News

Coca-Cola Consolidated Inc traded modestly higher in after-market hours following the announcement of a new zero-sugar prebiotic soda, despite recent volatility.

7 oct. 2026, 23:05 UTC

News

UBS reaffirms its Buy rating on BlackRock Inc, lowering the price target to $1.28K, as the stock remains flat in after-market trading.

Comparaison

Variation de prix

Takeda Pharmaceutical Co Ltd ADR prévision

Objectif de Prix

By TipRanks

136.38% hausse

Prévisions sur 12 Mois

Moyen 43.423 USD  136.38%

Haut 43.423 USD

Bas 43.423 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

1 ratings

1

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

133 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.